NEW YORK (Reuters Health) – Patients with high-risk esophageal varices treated with the beta-blocker carvedilol had lower rates of first bleeding episodes than patients treated with variceal band…
NEW YORK (Reuters Health) – Neoadjuvant hormonal therapy for prostate cancer may increase the risk of death in men with coronary artery disease-induced heart failure or myocardial infarction…
Jay Alberts, PhD, Assistant Staff, Lerner Research Institute, Cleveland Clinic, gives us an overview of Parkinson’s Disease and describes study results which showed that exercise therapy had a…
Jay Alberts, PhD, Assistant Staff, Lerner Research Institute, Cleveland Clinic, discusses research findings on forced exercise for patients with Parkinson’s Disease. Summary 1. Based on research findings, Parkinson’s…
NEW YORK (Reuters Health) – Long-term, high-dose ursodeoxycholic acid (UDCA) should not be used for treatment of primary sclerosing cholangitis because of the increased risk of severe adverse…
Michael Banks, MD sits down with Oliver Fein, MD, President of Physicians for a National Health Program (PNHP), to discuss the current debate over health care reform and…
NEW YORK (Reuters Health) – Because of their ability to prevent, reduce, and delay skeletal complications with multiple myeloma, bisphosphonates are an essential component of treatment for this…
NEW YORK (Reuters Health) – Adding endoscopic band ligation to treatment with nadolol and isosorbide does not further reduce the risk of recurrent bleeding with esophageal varices, according…
NEW YORK (Reuters Health) – Only about half the patients with severe mitral regurgitation who meet current heart society guidelines for surgical intervention actually undergo mitral surgery, according…
NEW YORK (Reuters Health) – Prior research has linked the thiazolidinediones pioglitazone and rosiglitazone with an increased risk of heart failure, myocardial infarction, and death, but new research…
